This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study design
The study was a multi-centre, prospective, randomised controlled trial. The number of centres (exercise pools) was not reported. The randomisation process was stratified according to gender. The participants were followed-up for 20-weeks. Twenty-one participants (16.8%) in the intervention group and 3 (3%) in the control group did not complete the study and were lost to follow-up. No significant differences in the baseline characteristics of the drop-outs and completers were reported. There was no blinding method for the assessment of outcomes.
Analysis of effectiveness
The analysis of the clinical study was performed on an intention to treat basis. The primary health outcomes used in the analysis were nonpreference-weighted outcomes. These included an assessment of arthritis-specific function using the Health Assessment Questionnaire (HAQ) for pain and disability; the perceived quality of life using the Perceived Quality of Life Scale (PQOL); and depressive symptoms, measured using the Centre for Epidemiological StudiesDepression Scale (CES-D). Adherence to the exercise protocol was also recorded.
The intervention and control groups were comparable in terms of gender, age, health status, or utilisation measures, with the exception of the number of medications used per week. The difference between the two groups in terms of the number of medications used weekly was no longer significant when one participant's medication count, which was more than two standard deviations (SDs) above the mean number, was removed from the analysis.
The outcome measures were compared used an analysis of covariance, which controlled for health outcome measures at baseline.
Effectiveness results
The HAQ disability score at baseline was 1.035 (SD=0.535, n=125) for the intervention group and 1.047 for the control group (SD=0.608, n=124). The postclass (20 weeks) HAQ disability score was 0.933 (SD=0.550, n=101) for the intervention group and 1.127 for the control group (SD=0.671, n=121). This difference was statistically significant, (p<0.015).
The HAQ pain score at baseline was 1.533 (SD=0.602, n=121) for the intervention group and 1.440 for the control group (SD=0.610, n=123). The postclass (20 weeks) HAQ pain score was 1.382 (SD=0.737, n=98) for the intervention group and 1.462 for the control group (SD=0.619, n=117). This difference was not statistically significant, (p<0.660).
The PQOL physical score at baseline was 5.741 (SD=1.622, n=122) for the intervention group and 5.919 for the control group (SD=1.729, n=124). The postclass (20 weeks) PQOL physical score was 6.396 (SD=1.697, n=101) for the intervention group and 5.790 for the control group (SD=1.752, n=121). This difference was statistically significant, (p<0.007).
The CES-D score at baseline was 7.261 (SD=5.308, n=123) for the intervention group and 7.715 for the control group (SD=4.995, n=120). The postclass (20 weeks) CES-D score was 6.956 (SD=4.729, n=101) for the intervention group and 8.092 for the control group (SD=6.005, n=113). This difference was not statistically significant, (p<0.096).
A total of 36 participants attended the aquatic exercise class at least twice per week for at least 16 weeks.
Clinical conclusions
The authors concluded that the aquatic exercises had better outcomes, as measured using HAQ and PQOL, than the controls. There was no difference in CES-D scores. The participants undergoing aquatic exercise did not report any improvements in pain scores.
Modelling
A multivariate general linear model was used to assess whether there were significant differences in the means of certain outcome variables. The covariates used in this model were the postclass difference scores for age, gender and a number of medical conditions.
Measure of benefits used in the economic analysis
Two preference-weighted health status measures were used in the economic analysis, the Quality of Well Being (QWB) scale and the single-item Current Health Desirability Weighting (CHDR). The QWB scale is a generic measure of health status with community-derived preference weights for use in cost-effectiveness analysis. The CHDR asks participants to rate the desirability of their current health status on a scale from 0 to 100, ranging from least desirable to most desirable. This outcome measure is specific to patients with osteoarthritis.
The participants were asked to complete the two health status measures, in the form of self-completion questionnaires, at baseline and 20 weeks later. A generalised linear model was used to compare QWB and CHDR for adherers, nonadherers and controls. The QALYs were calculated by multiplying the mean post-aquatic class QWB score and CHDR by the expected years of life remaining. The expected years of life remaining were derived from the ages of the participants and life tables. This was found to be 18.44 years. The QALYs were discounted at a rate of 3%.
Direct costs
The quantities and costs were not analysed separately. The quantities were estimated from a weekly diary in which the participants recorded the use of the following:
health care providers such as primary care physicians, arthritis specialists, podiatrists, chiropractors, surgeons, physical and occupational therapists, and home health care nurses; non-traditional therapy such as acupuncture and massage; 'other' arthritis-related care, such as wax therapy, hot gloves, or a transcutaneous electrical nerve stimulator unit; and arthritis-related household or chore-worker help.
The participants also recorded the use of arthritis-specific drugs, aids and devices, using questionnaires given at the beginning and end of the study period. The medicines itemised included over-the-counter pain-controlling drugs such as non-steroidal anti-inflammatory drugs, antirheumatic medications, muscle relaxants, antidepressants or sleep aids, and
